Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) COO Sanjay Gajendra sold 95,444 shares of the stock in a transaction on Monday, May 18th. The stock was sold at an average price of $225.02, for a total value of $21,476,808.88. Following the transaction, the chief operating officer owned 1,435,857 shares of the company’s stock, valued at approximately $323,096,542.14. This represents a 6.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Sanjay Gajendra also recently made the following trade(s):
- On Thursday, May 7th, Sanjay Gajendra sold 49,361 shares of Astera Labs stock. The stock was sold at an average price of $199.21, for a total value of $9,833,204.81.
- On Thursday, May 7th, Sanjay Gajendra sold 230,639 shares of Astera Labs stock. The stock was sold at an average price of $198.22, for a total value of $45,717,262.58.
Astera Labs Stock Performance
Shares of NASDAQ ALAB traded up $43.22 during mid-day trading on Wednesday, reaching $287.48. 10,253,769 shares of the company’s stock were exchanged, compared to its average volume of 5,914,570. The firm has a market capitalization of $49.28 billion, a price-to-earnings ratio of 194.24, a PEG ratio of 3.23 and a beta of 3.35. Astera Labs, Inc. has a 52-week low of $84.78 and a 52-week high of $287.70. The company’s 50-day moving average is $163.12 and its 200-day moving average is $157.97.
Institutional Investors Weigh In On Astera Labs
A number of hedge funds have recently bought and sold shares of the stock. Liontrust Investment Partners LLP raised its position in Astera Labs by 98.7% in the 1st quarter. Liontrust Investment Partners LLP now owns 105,270 shares of the company’s stock valued at $11,538,000 after purchasing an additional 52,284 shares in the last quarter. SOA Wealth Advisors LLC. acquired a new stake in Astera Labs in the 1st quarter valued at about $49,000. E20 Capital Ltd purchased a new position in shares of Astera Labs in the 1st quarter valued at about $33,310,000. Silicon Valley Capital Partners increased its holdings in shares of Astera Labs by 233.3% in the 1st quarter. Silicon Valley Capital Partners now owns 1,000 shares of the company’s stock valued at $110,000 after acquiring an additional 700 shares during the last quarter. Finally, Bank of America Corp DE increased its holdings in shares of Astera Labs by 20.1% in the 1st quarter. Bank of America Corp DE now owns 1,788,232 shares of the company’s stock valued at $195,990,000 after acquiring an additional 299,415 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on ALAB shares. Roth Mkm reiterated a “buy” rating and issued a $275.00 price objective on shares of Astera Labs in a report on Wednesday, May 6th. Barclays boosted their price objective on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Morgan Stanley increased their price target on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Susquehanna increased their price target on Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Finally, Citigroup increased their price target on Astera Labs from $200.00 to $245.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Fifteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus price target of $233.75.
View Our Latest Stock Analysis on Astera Labs
Key Headlines Impacting Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Wall Street optimism and a fresh analyst “buy” call helped fuel the rally, with investors viewing Astera Labs as a strong AI play. Astera Labs (ALAB) Soars 13% on Analyst ‘Buy’ Reco
- Positive Sentiment: Management commentary about a new switch timeline and potential revenue opportunities in optical networking boosted sentiment around future growth catalysts. Here’s why Astera Labs’ stock just staged a big gain
- Positive Sentiment: Traders also pointed to a “Power Inflow” alert and unusually heavy call-option buying, suggesting aggressive bullish positioning and momentum chasing in the stock. Astera Labs Shares Rise Over 6 Percent After Key Trading Signal
- Positive Sentiment: The stock is also being bid up after a Barron’s report said it is on pace for a record high, reinforcing the market’s view that Astera Labs is emerging as a notable AI infrastructure winner. Astera Labs Stock on Pace for Record High. Why It’s Up Double Digits for a Second Day.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
- Five stocks we like better than Astera Labs
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
